Skip to Content
DAEWOONG PHARMACEUTICAL CO.LTD.
About Daewoong
About Daewoong
Global Network
Company Culture
History
Ethics
Contact Us
R&D
R&D Centers
R&D Projects
Achievements
Research Result
Platform Technology
Manufacturing Capabilities
Plants
Smart Factory
FDF CDMO
Product
Biologics
Chemicals
CTD List
Newsroom
Press Release
PR Videos
Investors
Overview
Corperate Governance
Annual Reports
Stock Info
IR
Careers
EN
KR
EN
View all menu
About Daewoong
About Daewoong
Our Purpose
CEO Message
Affiliates
Global Network
Company Culture
History
Ethics
Compliance Program
CEO Message
CP Rating
CP Activities
Contact Us
R&D
R&D Centers
R&D Projects
Achievements
Research Result
Platform Technology
Manufacturing
Capabilities
Plants
Smart Factory
FDF CDMO
Product
Biologics
Chemicals
CTD List
Newsroom
Press Release
PR Videos
Investors
Overview
Corperate Governance
Overview
Board of Directors
Stockholder Info
Stockholder's meeting
Annual Reports
Balance Sheet
Income Statement
Credit Rating
Stock Info
Stock Info
Stock Status
IR
Events
IR Letter
Earnings announcement
Analysis Data
FAQ
Careers
Daewoong
Global Healthcare Group
The Best Partner for You
Chemicals
Making our world healthier together
Luphere
TM
Depot
3.75mg / Pre-filled syringe Inj.
Leuprorelin Acetate
Indication
Prostate cancer, Endometriosis, Pre-menopausal breast cancer, Uterine leiomyomata (Fibroids), Central Precocious Puberty
Olostar
TM
10/5, 10/10, 20/5, 20/10, 20/20, 40/10/, 40/20mg - Tab.
Olmesartan medoxomil, Rosuvastatin
Indication
Concomitant Hypertension and Dyslipidemia
URSA
TM
200, 300mg Tab. 200, 250mg Hard Cap.
UDCA (Ursodeoxycholic Acid)
Indication
PBC, Hepatitis C, Gallstone disease, Prevention of Gallstone